The Neutral rating suggests that UBS does not see significant upside or downside potential in the short term. The slight reduction in the price target from $66 to $65 indicates a marginally less optimistic outlook, but it is not a drastic change. Therefore, the short-term impact on AMN's stock price is likely to be neutral.